Skip to content

FREMED: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

FREMED

BE 0419.037.822
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€4,495
2024 · -€66-€4,430
Equity
-€22,959
2024 · -€18,464-€4,495
Cash
€2,787
2024 · €7,119-€4,332
Balance sheet total
€21,724
2024 · €22,334-€610

Largest movements

2024 to 2025
Assets
  • Cash -€4,332

    down €4,332 (-60.9%), from €7,119 to €2,787

    mainly Net result for the year (-€4,495) and Investment in fixed assets (net) (-€4,250)

  • Tangible fixed assets +€3,927

    new in 2025: €3,927

  • Receivables within one year -€883

    down €883 (-42.8%), from €2,064 to €1,181

    of which Trade receivables: -€676

  • Stocks and contracts +€573

    up €573 (+4.4%), from €13,120 to €13,693

Equity and liabilities
  • Other debts +€6,973

    up €6,973 (+21.1%), from €32,983 to €39,956

  • Profit (loss) carried forward -€4,495

    down €4,495 (-11.6%), from -€38,915 to -€43,410

  • Trade debts -€2,787

    down €2,787 (-44.4%), from €6,276 to €3,489

  • Tax, wage and social debts -€300

    down €300 (-19.5%), from €1,538 to €1,238

Income statement
  • Gross operating margin -€3,203

    down €3,203, from €598 to -€2,604

  • Other operating charges +€874

    up €874 (+170.3%), from €513 to €1,387

  • Depreciation +€323

    new in 2025: €323

  • Financial charges +€30

    up €30 (+19.9%), from €151 to €181

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€66
Gross operating margin -€3,203
Depreciation -€323
Other operating charges -€874
Financial charges -€30
Result 2025 -€4,495

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€82
Investment -€4,250
Financing €0
Cash 2024 €7,119
Net result for the year -€4,495
Depreciation +€323
Stocks and contracts -€573
Receivables within one year +€883
Deferred charges and accrued income -€106
Trade debts -€2,787
Tax, wage and social debts -€300
Other debts +€6,973
Investment in fixed assets (net) -€4,250
Cash 2025 €2,787
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €22,334 €21,724 -€610 -2.7%
Fixed assets 21/28 €31 €3,958 +€3,927 +12671.4%
Tangible fixed assets 22/27 - €3,927 +€3,927
Furniture and vehicles 24 - €3,927 +€3,927
Financial fixed assets 28 €31 €31 = 0.0%
Current assets 29/58 €22,303 €17,766 -€4,537 -20.3%
Stocks and contracts in progress 3 €13,120 €13,693 +€573 +4.4%
Stocks 30/36 €13,120 €13,693 +€573 +4.4%
Amounts receivable within one year 40/41 €2,064 €1,181 -€883 -42.8%
Trade receivables 40 €964 €289 -€676 -70.1%
Other amounts receivable 41 €1,100 €893 -€207 -18.8%
Cash at bank and in hand 54/58 €7,119 €2,787 -€4,332 -60.9%
Deferred charges and accrued income 490/1 - €106 +€106
Total equity and liabilities 10/49 €22,334 €21,724 -€610 -2.7%
Equity 10/15 -€18,464 -€22,959 -€4,495 -24.3%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €1,859 €1,859 = 0.0%
Non-distributable reserves 130/1 €1,859 €1,859 = 0.0%
Reserves not available under the articles 1311 €1,859 €1,859 = 0.0%
Profit (loss) carried forward 14 -€38,915 -€43,410 -€4,495 -11.6%
Amounts payable 17/49 €40,797 €44,683 +€3,886 +9.5%
Amounts payable within one year 42/48 €40,797 €44,683 +€3,886 +9.5%
Trade debts 44 €6,276 €3,489 -€2,787 -44.4%
Suppliers 440/4 €6,276 €3,489 -€2,787 -44.4%
Taxes, remuneration and social security 45 €1,538 €1,238 -€300 -19.5%
Taxes 450/3 €1,538 €1,238 -€300 -19.5%
Other amounts payable 47/48 €32,983 €39,956 +€6,973 +21.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 - €323 +€323
Other operating charges 640/8 €513 €1,387 +€874 +170.3%
Gross operating margin 9900 €598 -€2,604 -€3,203
Operating profit (loss) 9901 €85 -€4,315 -€4,400
Financial income 75/76B €0 - =
Recurring financial income 75 €0 - =
Financial charges 65/66B €151 €181 +€30 +19.9%
Recurring financial charges 65 €151 €181 +€30 +19.9%
Profit (loss) for the period before taxes 9903 -€66 -€4,495 -€4,430 -6742.4%
Profit (loss) for the period 9904 -€66 -€4,495 -€4,430 -6742.4%
Profit (loss) for the period to be appropriated 9905 -€66 -€4,495 -€4,430 -6742.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.